Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.1.1 (
hexokinase
)
5,274
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The reg 1 mutation will allow the expression of a cloned gene on a plasmid under the control of a GAL promoter in the presence of glucose. The metabolism of wild-type and reg l mutant strains was examined by in vivo (31)P nuclear magnetic resonance (NMR) spectroscopy. Transient profiles of glucose 6-phosphate, fructose 6-phosphate, fructose 1, 6-diphosphate, and 3-phosphoglycerate indicated that glucose was processed differently for the reg 1 strain despite similar cytoplasrnic pH values and ATP levels. Intracellular phosphate became depleted in the transition to quasi-steady state and limited glycolysis in the reg 1 strain. The glucose uptake step or
hexokinase
step appears to be altered in the reg 1 strain. The reg 1 strain utilized galactose faster than the wild-type strain under the conditions used for NMR analysis. These results are consistent with the hypothesis that the
REG
1 product operates early in the regulatory circuitry for glucose repression. This study illustrates the usefulness of transient information provided by NMR in understanding changes in the metabolism of genetically manipulated organisms.
...
PMID:Comparison of wild-type and Reg 1 mutant saccharomyces cerevisiae metabolic levels during glucose and galactose metabolism using 31P NMR. 1859 32